Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics... Show more
Industry Biotechnology
A.I.dvisor indicates that over the last year, ORYZF has been loosely correlated with CLDI. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ORYZF jumps, then CLDI could also see price increases.
| Ticker / NAME | Correlation To ORYZF | 1D Price Change % | ||
|---|---|---|---|---|
| ORYZF | 100% | N/A | ||
| CLDI - ORYZF | 37% Loosely correlated | +0.47% | ||
| PPBT - ORYZF | 28% Poorly correlated | -0.41% | ||
| DRUG - ORYZF | 25% Poorly correlated | -2.82% | ||
| GNNSF - ORYZF | 24% Poorly correlated | N/A | ||
| IPSC - ORYZF | 20% Poorly correlated | -4.10% | ||
More | ||||